Google
×
Any time
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
Verbatim
Pregnancy-associated plasma protein A (PAPP-A) is a key regulator of insulin-like growth factor bioavailability essential for normal fetal development.
People also ask
Mar 20, 2020 · Low PAPP-A serum levels in the first trimester of pregnancy are associated with short stature in offspring and de-novo development of maternal diabetes ...
PAPPA is a secreted protease whose main substrate is insulin-like growth factor binding proteins. Pappalysin-1 is also used in screening tests for Down syndrome ...
PAPP-A is a marker measured as part of the combined pregnancy screening blood test which is offered around 11-14 weeks of pregnancy. Why does PAPP-A matter in ...
Sep 18, 2024 · Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression. PAPP-A functions as a tumor suppressor and is downregulated in ...
PAPPA (Pappalysin 1) is a Protein Coding gene. Diseases associated with PAPPA include Placenta Disease and Chromosomal Triplication. Among its related pathways ...
Sep 10, 2021 · What is PAPP-A? PAPP-A is produced by the placenta. · How and when is it tested? The level of PAPP-A is assessed as part of the combined test.
Dec 22, 2022 · Pregnancy-associated plasma protein A (PAPP-A) is a zinc metalloprotease that explicitly cleaves IGFBPs (primarily IGFBP4 as well as IGFBP2 and ...
Reduced maternal serum PAPP-A is a major marker of Down syndrome in the first trimester of pregnancy. PAPP-A cleaves IGFBP-4 and -5 (insulin-like growth factor- ...
The role of PAPP-A in cystic disease appears to be regulation of the IGF-1 pathway and cellular proliferation in the kidney.